Zelenectide pevedotin (BT8009) clinical trials

Study of Zelenectide Pevedotin in Participants With Advanced Breast Cancer

This study looks at a new drug, zelenectide pevedotin, for advanced breast cancer. It's for people whose cancer has a specific marker called NECTIN4. The study aims to see how well it works and if it's safe for different types of breast cancer.